TO STUDY THE PREVALENCE AND CLINICAL PROFILE OF CHRONIC ATRIAL FIBRILLATION IN HOSPITALIZED PATIENTS
Objective: To determine the prevalence of chronic atrial fibrillation (AF) in a tertiary care center and to identify the clinical profile of chronic AF in hospitalized patients.
Methods: All patients admitted to Mamata General Hospital in medicine/cardiology wards with chronic AF (persistent and permanent) during the period January 2012 to December 2012 were included into the study. The principal exclusion criteria were new onset AF and acute AF.
Results: During the study period, 49 patients were admitted with chronic AF with an average of 45.44 years. A slight female dominance was seen with male: female ratio of 1:1.2. Half of the patients (51%) were below the age 50 years. The elderly age group comprised of only 16.3% of cases. The commonest presenting complaint was dyspnea followed by palpitation. Rheumatic valvular heart disease was seen more commonly in people below the age of 50 years whereas hypertension and ischemic heart disease after 50 years. Heart failure was the commonest condition associated with the chronic AF and was the cause of hospitalization in almost fifty percent of cases
Conclusion: Chronic AF is still a cause of concern in India in people below the age of 50 years due to high prevalence of rheumatic fever inspite of advances in the medical field.
24 April 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370 –2375.
- 2 Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN: The influence of atrial fibrillation on prognosis in mild to moderate heart failure: The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation. 1993; 87: VI102–VI110.
- 3 Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, and Stevenson LW: Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998; 32: 695–703.
- 4 Maisel WH, Rawn JD, Stevenson WG: Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001; 135: 1061–1073.
- 5 Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ, Solomon AJ: Acute myocardial infarction complicated by atrial fibrillation in the elderly: Prevalence and outcomes. Circulation. 2000; 101: 969–974.
- 6 Diker E, Aydogdu S, Ozdemir M, Kural T, Polat K, Cehreli S, Erdogan A, Goksel S: Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol. 1996; 77: 96–98.
- 7 Krahn AD, Manfreda J, Tate RB, Mathewson FA, and Cuddy TE: The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98: 476–484.
- 8 Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ: Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study. J Am Coll Cardiol. 1990; 15: 1279–1285.
- 9 Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM: New atrial fibrillation after acute myocardial infarction independently predicts death: The GUSTO-III experience. Am Heart J. 2000; 140: 878–885.
- 10 Buch P, Friberg J, Scharling H, Lange P, and Prescott E: Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J. 2003; 21: 1012–1016.
- 11 Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, Malouf JF, Ammash NM, Friedman PA, Somers VK: Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004; 110: 364–367.
- 12 Goldhaber SZ, Visani L, De Rosa M: Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999; 353: 1386–1389.
- 13 Woeber KA: Thyrotoxicosis and the heart. N Engl J Med. 1992; 327: 94–98.
- 14 Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ: Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004; 292: 2471–2477.
- 15 Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009; 104:1534-9
- 16 Lip GY. Golding DJ – A survey of atrial fibrillation in general practice. British Jr. of general practice. 1997; 47 (418) 285–289.
- 17 Lip GY, Beevers DG. ABC of atrial fibrillation: History, epidemiology, and importance of atrial fibrillation. BMJ 1995; 311:1361.
- 18 P.T. Onundarson, G. Thorgeirsson, E. Jonmundsson, N. Sigfusson and Th. Hardarson. Chronic atrial fibrillation— epidemiologic features and 14 year follow-up: A case control study. Eur Heart J. 1987; 8(5): 521-527.
- 19 Lok NS Lau Cp – Presentation and Management of patients admitted with atrial fibrillation. International Jr. of Cardiology. 1995; 48 (3): 271–278.
- 20 SM Vaziri, MG Larson, EJ Benjamin, and D Levy Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study Circulation. 1994; 89:724-730.
- 21 Scardi S, Mazzone C, Pandullo C, Goldstein D, Poletti A, Humar F. Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. Am Heart J 1999; 137:686691.